Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02037542 · ClinicalTrials.gov registry record · NA

A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer

A NA study of Weight, sponsored by Baptist Health South Florida.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02037542 is a NA study of Weight that has completed, run by Baptist Health South Florida. The registered enrollment target is 100 participants, below the 368-participant average among 5 other Weight trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02037542, a NA study of Weight, has completed, sponsored by Baptist Health South Florida.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the hypothesis that an intervention of lifestyle modification will positively impact women with breast cancer who are overweight and/or obese. To that end, our primary endpoint is to examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.

Conditions Studied

Interventions

  • BEHAVIORAL Diet and exercise

Study Locations (1)

Florida

  • South Miami Hospital - Miami

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-09
Est. Completion 2016-05
Phase NA

Sponsor

Baptist Health South Florida

40 total trials

What the Registry Record Tells You About NCT02037542

The ClinicalTrials.gov registry entry for NCT02037542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 368-participant average among 5 other Weight trials with a reported enrollment target (73% lower). The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Weight appearing as the primary indexed condition, and to 1 intervention - of which Diet and exercise is the first listed.

NCT02037542 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02037542 about?

NCT02037542 is a clinical study titled "A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer". The purpose of this study is to test the hypothesis that an intervention of lifestyle modification will positively impact women with breast cancer who are overweight and/or obese. To that end, our primary endpoint is to examine the effects of a practical lifestyle intervention that can be implemente...

What is the current status of trial NCT02037542?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-09. Estimated completion is 2016-05.

What conditions does trial NCT02037542 study?

This clinical trial studies the following conditions: Weight.

What interventions are being tested in trial NCT02037542?

The interventions under investigation include: Diet and exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02037542?

This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02037542 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.